40 related articles for article (PubMed ID: 28609652)
1. The full transforming capacity of MLL-Af4 is interlinked with lymphoid lineage commitment.
Lin S; Luo RT; Shrestha M; Thirman MJ; Mulloy JC
Blood; 2017 Aug; 130(7):903-907. PubMed ID: 28637661
[TBL] [Abstract][Full Text] [Related]
2. The MLL recombinome of acute leukemias in 2017.
Meyer C; Burmeister T; Gröger D; Tsaur G; Fechina L; Renneville A; Sutton R; Venn NC; Emerenciano M; Pombo-de-Oliveira MS; Barbieri Blunck C; Almeida Lopes B; Zuna J; Trka J; Ballerini P; Lapillonne H; De Braekeleer M; Cazzaniga G; Corral Abascal L; van der Velden VHJ; Delabesse E; Park TS; Oh SH; Silva MLM; Lund-Aho T; Juvonen V; Moore AS; Heidenreich O; Vormoor J; Zerkalenkova E; Olshanskaya Y; Bueno C; Menendez P; Teigler-Schlegel A; Zur Stadt U; Lentes J; Göhring G; Kustanovich A; Aleinikova O; Schäfer BW; Kubetzko S; Madsen HO; Gruhn B; Duarte X; Gameiro P; Lippert E; Bidet A; Cayuela JM; Clappier E; Alonso CN; Zwaan CM; van den Heuvel-Eibrink MM; Izraeli S; Trakhtenbrot L; Archer P; Hancock J; Möricke A; Alten J; Schrappe M; Stanulla M; Strehl S; Attarbaschi A; Dworzak M; Haas OA; Panzer-Grümayer R; Sedék L; Szczepański T; Caye A; Suarez L; Cavé H; Marschalek R
Leukemia; 2018 Feb; 32(2):273-284. PubMed ID: 28701730
[TBL] [Abstract][Full Text] [Related]
3. Replication Study: Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia.
Shan X; Fung JJ; Kosaka A; Danet-Desnoyers G;
Elife; 2017 Jun; 6():. PubMed ID: 28653617
[TBL] [Abstract][Full Text] [Related]
4. The molecular pathogenesis of the NUP98-HOXA9 fusion protein in acute myeloid leukemia.
Rio-Machin A; Gómez-López G; Muñoz J; Garcia-Martinez F; Maiques-Diaz A; Alvarez S; Salgado RN; Shrestha M; Torres-Ruiz R; Haferlach C; Larráyoz MJ; Calasanz MJ; Fitzgibbon J; Cigudosa JC
Leukemia; 2017 Sep; 31(9):2000-2005. PubMed ID: 28630438
[No Abstract] [Full Text] [Related]
5. MLL/WDR5 Complex Regulates Kif2A Localization to Ensure Chromosome Congression and Proper Spindle Assembly during Mitosis.
Ali A; Veeranki SN; Chinchole A; Tyagi S
Dev Cell; 2017 Jun; 41(6):605-622.e7. PubMed ID: 28633016
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of EZH2 mutant patients with myelodysplastic/myeloproliferative neoplasms.
Rinke J; Müller JP; Blaess MF; Chase A; Meggendorfer M; Schäfer V; Winkelmann N; Haferlach C; Cross NCP; Hochhaus A; Ernst T
Leukemia; 2017 Sep; 31(9):1936-1943. PubMed ID: 28626218
[TBL] [Abstract][Full Text] [Related]
7. Base excision repair proteins couple activation-induced cytidine deaminase and endonuclease G during replication stress-induced MLL destabilization.
Gole B; Mian E; Rall M; Wiesmüller L
Leukemia; 2018 Jan; 32(1):159-167. PubMed ID: 28626219
[TBL] [Abstract][Full Text] [Related]
8. Inotuzumab: from preclinical development to success in B-cell acute lymphoblastic leukemia.
Wynne J; Wright D; Stock W
Blood Adv; 2019 Jan; 3(1):96-104. PubMed ID: 30622147
[TBL] [Abstract][Full Text] [Related]
9. Structural and functional analysis of the DOT1L-AF10 complex reveals mechanistic insights into MLL-AF10-associated leukemogenesis.
Zhang H; Zhou B; Qin S; Xu J; Harding R; Tempel W; Nayak V; Li Y; Loppnau P; Dou Y; Min J
Genes Dev; 2018 Mar; 32(5-6):341-346. PubMed ID: 29563185
[TBL] [Abstract][Full Text] [Related]
10. Piribedil disrupts the MLL1-WDR5 interaction and sensitizes MLL-rearranged acute myeloid leukemia (AML) to doxorubicin-induced apoptosis.
Zhang X; Zheng X; Yang H; Yan J; Fu X; Wei R; Xu X; Zhang Z; Yu A; Zhou K; Ding J; Geng M; Huang X
Cancer Lett; 2018 Sep; 431():150-160. PubMed ID: 29857126
[TBL] [Abstract][Full Text] [Related]
11. Targeting epigenetic programs in MLL-rearranged leukemias.
Bernt KM; Armstrong SA
Hematology Am Soc Hematol Educ Program; 2011; 2011():354-60. PubMed ID: 22160057
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs mark in the MLL-rearranged leukemia.
Benetatos L; Vartholomatos G
Ann Hematol; 2013 Nov; 92(11):1439-50. PubMed ID: 23728610
[TBL] [Abstract][Full Text] [Related]
13. Paradoxical Effects of MLL Paralogs in MLL-Rearranged Leukemia.
Thirman MJ
Cancer Cell; 2017 Jun; 31(6):729-731. PubMed ID: 28609652
[TBL] [Abstract][Full Text] [Related]
14. MLL2, Not MLL1, Plays a Major Role in Sustaining MLL-Rearranged Acute Myeloid Leukemia.
Chen Y; Anastassiadis K; Kranz A; Stewart AF; Arndt K; Waskow C; Yokoyama A; Jones K; Neff T; Lee Y; Ernst P
Cancer Cell; 2017 Jun; 31(6):755-770.e6. PubMed ID: 28609655
[TBL] [Abstract][Full Text] [Related]
15. Distinct pathways affected by menin versus MLL1/MLL2 in MLL-rearranged acute myeloid leukemia.
Chen Y; Jones KL; Anastassiadis K; Kranz A; Stewart AF; Grembecka J; Meyerson M; Ernst P
Exp Hematol; 2019 Jan; 69():37-42. PubMed ID: 30315824
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
